FDA Inspection 964991 — Carter BloodCare - Irving

Carter BloodCare - Irving — FEI 3003103575

The FDA completed an inspection of Carter BloodCare - Irving on March 23, 2016 in Irving, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 23, 2016
Fiscal Year
2016
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Irving, TX (United States)